Stock-Based Compensation

9 Months Ended

Sep. 30, 2020

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation

Note 8 – Stock-Based Compensation

The Amended and Restated Omnibus Stock and Performance Compensation Plan (the “Omnibus Plan”) permits the issuance of up to 1,500,000 shares of the Company’s common stock in the form of stock options, SARs, restricted stock, restricted stock units and performance awards. The Company may issue shares out of treasury stock for these awards. During the nine months ended September 30, 2020, 33,568 restricted shares, 32,910 performance-based restricted shares, and no SARs were granted under the Omnibus Plan. Stock-based compensation expense for the three months ended September 30, 2020 and 2019 was $800,000 and $869,000, respectively, and $2,277,000 and $2,286,000 for the nine months ended September 30, 2020 and 2019, respectively.

Restricted Stock

Restricted shares granted to Company employees are amortized to expense over the three-year cliff vesting period. Restricted shares granted to members of the Board of Directors are amortized to expense over a one-year service period, with the exception of those shares granted in lieu of cash payments for retainer fees which are expensed in the period earned.

As of September 30, 2020, the total unrecognized compensation expense related to non-vested restricted shares was $1,674,000, and the related weighted-average period over which it is expected to be recognized is approximately 0.69 years.

Following is a summary of the activity of the restricted stock:

	Nine Months Ended September 30, 2020
	Shares		Fair Value
Balance at December 31, 2019		123,272	$	47.24
Granted		33,568		47.83
Vested		(20,369)		49.32
Forfeited		(4,962)		50.08
Balance at September 30, 2020		131,509	$	46.96

Performance-Based Restricted Stock

The Company has granted three-year performance based restricted stock (“PBRS”) awards which are contingent upon the Company’s achievement of pre-established financial goals over a three-year cliff vest period. The number of shares issued ranges from 0% to 150% of the target opportunity based on the actual achievement of financial goals for the three-year performance period.

-14-

Following is a summary of the activity of the PBRS, based on target value:

	Nine Months Ended September 30, 2020
	Shares		Fair Value
Balance at December 31, 2019		102,116	$	49.13
Granted		32,910		54.02
Vested		(29,175)		49.33
Forfeited		(7,441)		50.08
Balance at September 30, 2020		98,410	$	50.64

The PBRS that vested during the nine months ended September 30, 2020 achieved financial goals of 117.3%, resulting in the issuance of 34,222 shares of common stock. The outstanding PBRS at September 30, 2020 will vest at scheduled vesting dates and the actual number of shares of common stock issued will range from 0% to 150% of the target opportunity based on the actual achievement of financial goals for the respective three-year performance period.

SARs

There were no SARs granted and no expense recognized during the three months ended September 30, 2020. Following is a summary of the activity of the Company’s SARs program for the nine-month period ended September 30, 2020:

	Shares	Weighted- Average Exercise Price		Average Remaining Contractual Term Years	Aggregate Intrinsic Value (In thousands)
Balance at December 31, 2019	155,292	$	32.58	2.92	$	3,908
Exercised	(10,293)		26.72	—		—
Exercisable at September 30, 2020	144,999	$	32.99	2.20	$	1,247

There were no non-vested SARs at September 30, 2020.